Semaglutide and GLP-1 analogues as weight-loss agents
Semaglutide and GLP-1 analogues as weight-loss agents
About this item
Full title
Author / Creator
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
The increasing global frequency of obesity and its resultant health effects are well documented.1–4 Drug development for obesity has been hampered by concerns over cardiovascular safety and a paucity of significant efficacy.1 One possible pharmaceutical solution to promote weight loss lies in the glucagon-like peptide-1 (GLP-1) analogue class of dr...
Alternative Titles
Full title
Semaglutide and GLP-1 analogues as weight-loss agents
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2090330822
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2090330822
Other Identifiers
ISSN
0140-6736
E-ISSN
1474-547X
DOI
10.1016/S0140-6736(18)31826-9
